Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE003854 |
ID: | TCMBANKHE003854 |
植物拉丁名: |
|
功能与主治: | See Glycyrrhiza uralensis ./See Glycyrrhiza uralensis. |
药用植物名: | 粗毛甘草 |
药用部位: | root and rhizome |
TCM_ID_id: | 3549 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN013366 | glyeurysaponin | C42H62O16 | 822.9 g/mol | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN020048 | glycyroside | Glycyroside; LMPK12050024; Formononetin 7-O-apiosyl-(1->2)-glucoside | C27H30O13 | 562.52 | COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)OC4C(C(C(C(O4)CO)O)O)OC5C(C(CO5)(CO)O)O |
| TCMBANKIN029503 | isogosferol | 9-((2-Hydroxy-3-methyl-3-butenyl)oxy)-7H-furo(3,2-g)(1)benzopyran-7-one; AKOS032948613; Isogosferol; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-((2-hydroxy-3-methyl-3-butenyl)oxy)-; Isogospherol; 9-[(2-HYDROXY-3-METHYLBUT-3-EN-1-YL)OXY]FURO[3,2-G]CHROMEN-7-ONE; AC1L3XHE; MEGxp0_000940; 9-(2-hydroxy-3-methylbut-3-enoxy)furo[3,2-g]chromen-7-one; (+)-Isogospherol; 53319-52-1; RTUPRHIHXSAWDP-UHFFFAOYSA-; InChI=1/C16H14O5/c1-9(2)12(17)8-20-16-14-11(5-6-19-14)7-10-3-4-13(18)21-15(10)16/h3-7,12,17H,1,8H2,2H3; SCHEMBL2468855 | C16H14O5 | 286.28 | CC(=C)C(COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)O |
| TCMBANKIN030693 | liquoric acid | liquoricacid | C30H44O5 | 484.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CC5C6(C4CC(C(C6)O5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN036866 | glycyrrhizic acid | glycyrrhizicacid; CS-W019908; Glycyrrhizic acid | C42H62O16 | 822.93 | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C |
| TCMBANKIN036867 | glycyrrhetinic acid | beta-Glycyrrhetic acid; glycyrrhetinicacid; 3-hydroxy-11-oxoolean-12-en-29-oate; (2S,4aS,6aS,6bR,10S,12aS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; LT00233150; Glycyrrhetic acid; Glycyrrhetinic; 3b-hydroxy-11-oxo-Olean-12-en-30-oic acid; 3-hydroxy-11-oxoolean-12-en-29-oic acid (ACD/Name 4.0); 18b-Glycyrrhetic acid; Glycyrrhetin; Glycyrrhetinate; 3b-Hydroxy-11-oxoolean-12-en-30-oic acid; 18b-Glycyrrhtinic acid; Biosone; 3b-Hydroxy-11-oxoolean-12-en-30-oate; 3-Glycyrrhetinic acid; SCHEMBL13144257; 18b-Glycyrrhetinic acid; NCGC00186652-01; 3b-hydroxy-11-oxo-Olean-12-en-30-oate; b-glycyrrhetic acid; (2S,4AS,6AS,6BR,10S,12AS)-10-HYDROXY-2,4A,6A,6B,9,9,12A-HEPTAMETHYL-13-OXO-3,4,5,6,7,8,8A,10,11,12,12B,14B-DODECAHYDRO-1H-PICENE-2-CARBOXYLIC ACID; a-glycyrrhetinic acid | C30H46O4 | 470.68 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
| TCMBANKIN037976 | 3'-(γ,γ-Dimethylallyl)-kievitone | 3'(γ,γ-dimethylallyl)-kievitone | 424.53 | ||
| TCMBANKIN038308 | isoliquiritin | MolPort-001-742-630; 7014-39-3; 5041-81-6; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-(beta-D-glucopyranosyloxy)phenyl)-, (2E)-; C16978; Q-100563; BDBM50362885; (E)-1-(2,4-dihydroxyphenyl)-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]prop-2-en-1-one; SCHEMBL676338; 4-beta-D-glucopyranosyloxy-2',4'-dihydroxy-trans-chalcone; I07-0258; Isoliquiritin; X1193; 2Y348H1V4W; MEGxp0_001945; YNWXJFQOCHMPCK-LXGDFETPSA-N; CHEMBL599763; UNII-2Y348H1V4W; AKOS015897131; X1167; AC1NSX26; BG01706425; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-[4-(.beta.-D-glucopyranosyloxy)phenyl]-, (2E)-; AK554321; AT-28971; 4-[(1E)-3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]phenyl beta-D-glucopyranoside; N1750; (E)-1-(2,4-dihydroxyphenyl)-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one; MFCD00272145; ZINC33832004; LMPK12120021; 4-(beta-D-Glucopyranosyloxy)-2',4'-dihydroxychalcone; AK544982; CHEBI:80839; Neoisoliquritin | C21H22O9 | 418.394 | c1([H])c(O[H])c(C(=O)\C([H])=C([H])\c2c([H])c([H])c(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])c([H])c2[H])c([H])c([H])c1O[H] |
| TCMBANKIN039911 | Glyasperin M | 368.4 g/mol | |||
| TCMBANKIN040273 | Licocoumarone | ZINC3648307; SCHEMBL758659; licocoumarone; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)benzofuran-2-yl]benzene-1,3-diol; BDBM50325939; AIDS-166092; AC1L9XR8; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)-1-benzofuran-2-yl]benzene-1,3-diol; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)-2-benzofuranyl]benzene-1,3-diol; CHEMBL611368; AIDS166092; 4-[6-Hydroxy-4-methoxy-5-(3-methyl-but-2-enyl)-benzofuran-2-yl]-benzene-1,3-diol; 2-(2',4'-dihydroxyphenyl)-6-hydroxy-5-isopentenyl-4-methoxybenzofuran; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)benzofuran-2-yl]resorcinol; LMPK12160045; 4-[6-Hydroxy-4-methoxy-5-(3-methyl-2-butenyl)-2-benzofuranyl]-1,3-benzenediol, 9CI; 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)-1-benzofuran-2-yl]benzene-1,3-diol; CHEBI:69098; 2-(3,4-Dihydroxyphenyl)-6-hydroxy-4-methoxy-5-prenylbenzofuran | C20H20O5 | 340.37 | CC(=CCC1=C(C2=C(C=C1O)OC(=C2)C3=C(C=C(C=C3)O)O)OC)C |
| TCMBANKIN040550 | Glyasperin C | 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chroman-3-yl]benzene-1,3-diol; AIDS-096014; 4-[(R)-7-Hydroxy-5-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl]-benzene-1,3-diol; 4-((R)-7-Hydroxy-5-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl)-benzene-1,3-diol; 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)-3-chromanyl]benzene-1,3-diol; AIDS096014; 4-[(3R)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chroman-3-yl]resorcinol; 142474-53-1; glyasperin c | C21H24O5 | 356.41 | CC(=CCC1=C(C2=C(C=C1O)OCC(C2)C3=C(C=C(C=C3)O)O)OC)C |
| TCMBANKIN040788 | liquiritin | (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxyphenyl]chroman-4-one; CTK8G0592; 7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one; MCULE-9356107980; 4H-1-Benzopyran-4-one, 2-(4-(beta-D-glucopyranosyloxy)phenyl)-2,3-dihydro-7-hydroxy-, (S)-; 7-Hydroxyflavanone 4'-O-glucoside; (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]chroman-4-one; (2S)-7-hydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chroman-4-one; MLS000575018; AIDS166098; 4',7-Dihydroxyflavanone 4'-(beta-D-glucopyranoside); 551-15-5; SMR000232362; AIDS-166098; Likviritin; 4',7-Dihydroxyflavanone 4'-(beta-D-glucoside); 100483-53-2; MolPort-021-804-452; 17654-21-6; Liquiritoside; 30372-08-8; (S)-7-Hydroxy-2-[4-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-phenyl]-chroman-4-one; 31564-20-2; (2S)-7-hydroxy-2-[4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]-4-chromanone; (S)-2-(4-(beta-D-Glucopyranosyloxy)phenyl)-2,3-dihydro-7-hydroxy-4H-1-benzopyran-4-one; LMPK12140021 | C21H22O9 | 418.394 | c1([H])c([H])c(C(=O)C([H])([H])[C@]([H])(c2c([H])c([H])c(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])c([H])c2[H])O4)c4c([H])c1O[H] |
| TCMBANKIN043419 | glyasperin E | glyasperin e | 444.51 | CC(=CCC1=C(C=C2C(=C1O)C(=O)C(=CO2)OC3=C(C=C(C=C3)O)O)OC)C | |
| TCMBANKIN044686 | Isoglycyrol | 1H,7H-Benzofuro(3,2-c)pyrano(3,2-g)(1)benzopyran-7-one, 2,3-dihydro-10-hydroxy-13-methoxy-3,3-dimethyl-; AIDS095930; AIDS-095930; LMPK12090045; 23013-86-7; isoglycyrol; 10-Hydroxy-13-methoxy-3,3-dimethyl-2,3-dihydro-1H-benzofuro[3,2-c]pyrano[3,2-g][1]benzopyran-7-one | C21H18O6 | 366.36 | CC1(CCC2=C(O1)C=C3C(=C2OC)C4=C(C5=C(O4)C=C(C=C5)O)C(=O)O3)C |
| TCMBANKIN045392 | glyasperin k | C22H24O6 | 384.4 g/mol | CC(=CCC1=C(C=C2C(=C1O)C(=O)C(CO2)C3=C(C=C(C=C3)OC)O)OC)C | |
| TCMBANKIN046128 | glabrolide | C30H44O4 | 468.67 | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC6(CC5OC6=O)C)C)C)C)C | |
| TCMBANKIN046558 | Topazolin | 368.4 g/mol | |||
| TCMBANKIN047042 | Glyasperin A | 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromen-4-one; 3,5,7-Trihydroxy-2-(4-hydroxy-3-(3-methyl-but-2-enyl)-phenyl)-6-((Z)-3-methyl-but-2-enyl)-1-benzopyran-4-one; AIDS095973; 3,5,7-Trihydroxy-2-[4-hydroxy-3-(3-methyl-but-2-enyl)-phenyl]-6-((Z)-3-methyl-but-2-enyl)-1-benzopyran-4-one; 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)-4-chromenone; AIDS-095973; 142474-52-0; 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromone; glyasperin a | 422.47 | ||
| TCMBANKIN047119 | Isoglycycoumarin | 368.38 | |||
| TCMBANKIN047231 | Semilicoisoflavone B | 5,7,8'-Trihydroxy-2',2'-dimethyl-2'H-(3,6')bi(1-benzopyranyl)-4-one; 5,7,8'-Trihydroxy-2',2'-dimethyl-2'H-[3,6']bi[1-benzopyranyl]-4-one; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-chromen-6-yl)chromone; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-chromen-6-yl)chromen-4-one; AIDS095919; AIDS-095919; 129280-33-7; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethylchromen-6-yl)chromen-4-one; semilicoisoflavone b; 5,7-dihydroxy-3-(8-hydroxy-2,2-dimethyl-6-chromenyl)-4-chromenone | 352.34 | ||
| TCMBANKIN047243 | glyasperin F | glyasperin f | C20H18O6 | 354.4 g/mol | CC1(C=CC2=C(C=CC(=C2O1)C3COC4=CC(=CC(=C4C3=O)O)O)O)C |
| TCMBANKIN047857 | Glyasperin B | glyasperin b | 370.4 | ||
| TCMBANKIN048103 | Licorisoflavan A | CHEMBL598721 | 438.6 g/mol | ||
| TCMBANKIN048418 | Dehydroglyasperin C | 354.4 g/mol | |||
| TCMBANKIN048516 | Glyasperin D | 370.439 | |||
| TCMBANKIN049912 | Licoflavone B | 390.5 g/mol | |||
| TCMBANKIN058585 | norlobelanine | isolobelanine | C21H23NO2 | 321.4 g/mol | C1CC(NC(C1)CC(=O)C2=CC=CC=C2)CC(=O)C3=CC=CC=C3 |
| TCMBANKIN058798 | Glycyrol | MLS000697623; C16968; MolPort-039-339-022; AIDS095929; Neoglycyrol; 4CN-3163; CHEMBL132695; AKOS032949068; ZINC13130921; CHEBI:80832; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)-[1]benzoxolo[3,2-c]chromen-6-one; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)-[1]benzofuro[3,2-c]chromen-6-one; AIDS-095929; HMS2270J05; 3,9-Dihydroxy-1-methoxy-2-(3-methyl-but-2-enyl)-benzofuro[3,2-c][1]benzopyran-6-one; 23013-84-5; DTXSID00177569; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)-6-benzofurano[3,2-c]chromenone; SCHEMBL758197; AC1NSZ1D; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)benzofuro[3,2-c]chromen-6-one; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-enyl)benzofurano[3,2-c]chromen-6-one; SMR000470955; 3,9-dihydroxy-1-methoxy-2-(3-methylbut-2-en-1-yl)-6H-[1]benzofuro[3,2-c][1]benzopyran-6-one; 3,9-Dihydroxy-1-methoxy-2-prenylcoumestan; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-1-methoxy-2-(3-methyl-2-butenyl)-; glycyrol;neoglycyrol | C21H18O6 | 366.4 g/mol | CC(=CCC1=C(C2=C(C=C1O)OC(=O)C3=C2OC4=C3C=CC(=C4)O)OC)C |
| TCMBANKIN059639 | Isoglycyrol | C21H18O6 | 366.36 | CC1(CCC2=C(O1)C=C3C(=C2OC)C4=C(C5=C(O4)C=C(C=C5)O)C(=O)O3)C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab